Defunct Company
Total Trials
8
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,059
NCT01134328
Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model
Phase: Phase 2
Role: Lead Sponsor
Start: May 31, 2010
Completion: Jul 31, 2010
NCT01332188
Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model
Phase: Phase 2/3
Start: Apr 30, 2011
Completion: Oct 31, 2011
NCT01495338
A Comparison of the Safety and Comfort of AC-170
Phase: Phase 1
Start: Dec 31, 2011
Completion: Dec 31, 2011
NCT01551056
A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)
Phase: Phase 3
Start: Mar 31, 2012
Completion: Jun 30, 2012
NCT01685242
A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
Start: Sep 30, 2012
Completion: Nov 30, 2012
NCT01881113
A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
Start: Jun 30, 2013
Completion: Oct 31, 2013
NCT02132169
A Multi-Center Study Evaluating the Safety of AC-170 0.24%
Start: May 31, 2014
Completion: Oct 31, 2014
NCT02173249
A Single-Center, Open-Label, Study of the Plasma Pharmacokinetics and Safety of AC-170 0.24%
Start: Jun 30, 2014
Completion: Aug 31, 2014